Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual PI-Based HAART vs Multi-NRTI ART in ART-Experienced Children and Youth with Virologic Failure
NCT00102206Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lopinavir + ritonavir, saquinavir, emtricitabine, abacavir, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
lopinavir + ritonavirsaquinaviremtricitabineabacavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00102206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102206.